Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 1, 2006, Pages

  Takeuchi, Kazuhiko ^a   Miyata, Noriyuki ^b   Renic, Marija ^a   Harder, David R ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

20 hydroxyeicosatetraenoic acid; Nitric oxide; Subarachnoid hemorrhage

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; HEMOGLOBIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; FORMAMIDE DERIVATIVE; HYDROXYICOSATETRAENOIC ACID; MORPHOLINE DERIVATIVE; N (3 CHLORO 4 MORPHOLIN 4 YL) PHENYL N' HYDROXYIMIDO FORMAMIDE; N-(3-CHLORO-4-MORPHOLIN-4-YL) PHENYL-N'-HYDROXYIMIDO FORMAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BLOOD CLOTTING; BRAIN BLOOD VESSEL; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION; ANIMAL; BRAIN; BRAIN CIRCULATION; DRUG EFFECT; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; VASCULARIZATION;

ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; FORMAMIDES; HEMOGLOBINS; HYDROXYEICOSATETRAENOIC ACIDS; MALE; MORPHOLINES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; TIME FACTORS; VASOCONSTRICTION;

EID: 33644833670     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00445.2005     Document Type: Article

References (57)

1. Alonso-Galicia M, Hudetz AG, Shen H, Harder DR, and Roman RJ. Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation. Stroke 30: 2727-2734, 1999.
2. Alonso-Galicia M, Maier KG, Greene AS, Cowley AW Jr, and Roman RJ. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283: R60-R68, 2002.
3. Alonso-Galicia M, Sun CW, Falck JR, Harder DR, and Roman RJ. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. Am J Physiol Renal Physiol 275: F370-F378, 1998.
4. Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins ALIII, and Vallabhajosyula P. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 42: 352-360, 1998.
5. Biller J, Godersky JC, and Adams HP Jr. Management of aneurysmal subarachnoid hemorrhage. Stroke 19: 1300-1305, 1988.
6. Cambj-Sapunar L, Yu M, Harder DR, and Roman RJ. Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke 34: 1269-1275, 2003.
7. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid hemorrhage. Pharmacol Ther 66: 259-284, 1995.
8. D'Avella D, Germano A, Santoro G, Costa G, Zuccarello M, Caputi AP, Hayes RL, and Tomasello F. Effect of experimental subarachnoid hemorrhage on CSF eicosanoids in the rat. J Neurotrauma 7: 121-129, 1990.
9. G-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun 176: 1136-1111, 1991.
10. Foley PL, Caner HH, Kassell NF, and Lee KS. Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 34: 108-112, 1994.
11. 2+ current. J Physiol 507: 771-781, 1998.
12. Grasso G. An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Rev 44: 49-63, 2004.
13. Gryglewski RJ, Palmer RM, and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454-456, 1986.
14. Hacein-Bey L, Harder DR, Meier HT, Lauer KK, and Roman RJ. Improvement in angiographic vasospasm with a 20-HETE enzyme inhibitor in a subarachnoid hemorrhage dog model (Abstract). American Society of Neuroradiology 42nd Annual Meeting, Seattle, WA. Proc Am Soc Neuroradiol Abstract 04-O-722-ASNR, 2004.
15. Hacein-Bey L, Roman RJ, Lemke DM, Lauer KK, Varelas PN, Torbey MT, Cusick JF, and Harder DR. Evaluation of 20-hydroxyeiscosatetraenoic acid (20-HETE) levels in normal and abnormal blood and CSF (Abstract). American Society of Neuroradiology 42nd Annual Meeting, Seattle, WA. Proc Am Soc Neuroradiol: Abstract 04-O-738-ASNR, 2004.
16. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, and Roman R. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol Heart Circ Physiol 266: H2098-H2107, 1994.
17. Hercule HC, Wang MH, and Oyekan AO. Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat. J Physiol 551: 971-979, 2003.
18. Hirashima Y, Endo S, Kato R, and Takaku A. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880. J Neurosurg 84: 826-830, 1996.
19. Hoffman SW, Moore S, and Ellis EF. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke 28: 844-849, 1997.
20. Hoffman SW, Rzigalinski BA, Willoughby KA, and Ellis EF. Astrocytes generate isoprostanes in response to trauma or oxygen radicals. J Neurotrauma 17: 415-420, 2000.
21. Hudetz AG, Lee JG, Smith JJ, Bosnjak ZJ, and Kampine JP. Effects of volatile anesthetics on cerebrocortical laser Doppler flow: hyperemia, autoregulation, carbon dioxide response, flow oscillations, and role of nitric oxide. Adv Pharmacol 31: 577-593, 1994.
22. Kehl F, Cambj-Sapunar L, Maier KG, Miyata N, Kametani S, Okamoto H, Hudetz AG, Schulte ML, Zagorac D, Harder DR, and Roman RJ. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol 282: H1556-H1565, 2002.
23. Kehl F, Maier KG, Miyata N, Kametani S, Falck JR, Harder DR, and Roman RJ. The 20-HETE antagonist WIT-002 attenuates the acute reduction of cerebral blood flow after subarachnoid hemorrhage in the rat (Abstract). FASEB J 16: A845, 2002.
24. Kuroki M, Kanamaru K, Suzuki H, Waga S, and Semba R. Effect of vasospasm on heme oxygenases in a rat model of subarachnoid hemorrhage. Stroke 29: 683-688, 1998.
25. Kusaka G, Kimura H, Kusaka I, Perkins E, Nanda A, and Zhang JH. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 99: 383-390, 2003.
26. Lan C, Das D, Wloskowicz A, and Vollrath B. Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C. Am J Physiol Heart Circ Physiol 286: H165-H173, 2004.
27. Lange A, Gebremedhin D, Narayanan J, and Harder DR. 20- Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J Biol Chem 272: 27345-27352, 1997.
28. Loscalzo J and Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 38: 87-104, 1995.
29. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, and Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72: 126-136, 1993.
30. Macdonald RL and Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22: 971-982, 1991.
31. Macdonald RL, Weir BK, Marton LS, Zhang ZD, Sajdak M, Johns LM, Kowalczuk A, and Borsody M. Role of adenosine 5′-triphosphate in vasospasm after subarachnoid hemorrhage: human investigations. Neurosurgery 48: 854-862, 2001.
32. Miyata N, Seki T, Tanaka Y, Omura T, Taniguchi K, Doi M, Bandou K, Kametani S, Sato M, Okuyama S, Cambj-Sapunar L, Harder DR, and Roman RJ. Beneficial effects of a new 20-HETE synthesis inhibitor, TS-011, on hemorrhagic and ischemic stroke. J Pharmacol Exp Ther 314: 77-85, 2005.
33. Obara K, Nishizawa S, Koide M, Nozawa K, Mitate A, Ishikawa T, and Nakayama K. Interactive role of protein kinase C-delta with rho-kinase in the development of cerebral vasospasm in a canine two-hemorrhage model. J Vasc Res 42: 67-76, 2005.
34. Oyekan A, Balazy M, and McGiff JC. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol Regul Integr Comp Physiol 273: R293-R300, 1997.
35. Oyekan AO and McGiff JC. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat. Am J Physiol Regul Integr Comp Physiol 274: R52-R61, 1998.
36. Pickard JD, Walker V, Brandt L, Zygmunt S, and Smythe J. Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemorrhage on CSF eicosanoids. Acta Neurochir (Wien) 129: 152-157, 1994.
37. Pilitsis JG, Coplin WM, O'Regan MH, Wellwood JM, Diaz FG, Fairfax MR, Michael DB, and Phillis JW. Free fatty acids in human cerebrospinal fluid following subarachnoid hemorrhage and their potential role in vasospasm: a preliminary observation. J Neurosurg 97: 272-279, 2002.
38. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105: 23-56, 2005.
39. Poloyac SM, Reynolds RB, Yonas H, and Kerr ME. Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage. J Neurosci Methods 4: 257-263, 2005.
40. Randriamboavonjy V, Busse R, and Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 41: 801-806, 2003.
41. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
42. Rey FE, Li Carretero OA XC, Garvin JL, and Pagano PJ. Perivascular superoxide anion contributes to impairment of endothelium dependent relaxation: role of gp91 (phox). Circulation 106: 2497-5023, 2002.
43. Saida A, Ito H, Shibuya T, and Watanabe Y. Time-course alterations of monoamine levels and cerebral blood flow in brain regions after subarachnoid hemorrhage in rats. Brain Res Bull 43: 69-80, 1997.
44. Sakamoto M, Takaki E, Yamashita K, Watanabe K, Tabuchi S, Watanabe T, and Satoh K. Nonenzymatic derived lipid peroxide, 8-iso-PGF2 alpha, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model. Neurol Res 24: 301-306, 2002.
45. Sehba FA, Chereshnev I, Maayani S, Friedrich V Jr, and Bederson JB. Nitric oxide synthase in acute alteration of nitric oxide levels after subarachnoid hemorrhage. Neurosurgery 55: 671-677, 2004.
46. Seifert V, Loffler BM, Zimmermann M, Roux S, and Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82: 55-62, 1995.
47. + channel activity and vascular tone in renal arterioles. Circ Res 83: 1069-1079, 1998.
48. Sun CW, Falck JR, Okamoto H, Harder DR, and Roman RJ. Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries. Am J Physiol Heart Circ Physiol 279: H339-H350, 2000.
49. Takeuchi K, Renic M, Bohman QC, Harder DR, Miyata N, and Roman RJ. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE. Am J Physiol Heart Circ Physiol 289: H2203-H2211, 2005.
50. Vazquez B, Rios A, and Escalante B. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. Life Sci 56: 55-66, 1995.
51. Wickman G, Lan C, and Vollrath B. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm. Circ Res 92: 809-816, 2003.
52. Yamaguchi M, Zhou C, Nanda A, and Zhang JH. Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke 35: 1750-1755, 2004.
53. Yu M, Cambj-Sapunar L, Kehl F, Maier KG, Takeuchi K, Miyata N, Ishimoto T, Reddy LM, Falck JR, Gebremedhin D, Harder DR, and Roman RJ. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. Eur J Pharmacol 486: 297-306, 2004.
54. Yu M, Sun CW, Maier KG, Harder DR, and Roman RJ. Mechanism of cGMP contribution to the vasodilator response to NO in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol 282: H1724-H1731, 2002.
55. Zagorac D, Yamura K, Zheng C, Roman RJ, and Harder DR. The effect of superoxide anion on autoregulation of cerebral blood flow. Stroke In press.
56. Zhao X, Falck JR, Gopal VR, Inscho EW, and Imig JD. P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid. J Pharmacol Exp Ther 311: 1211-1217, 2004.
57. + channel in renal arterioles. Am J Physiol Regul Integr Comp Physiol 270: R228-R237, 1996.